NBYライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	2.54M
平均出来高	2.86M
時価総額	2.84M
EPS	$0 ( 2024-04-04 )
次の収益日	( $-0.150 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0200
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-09	Freiman Paul E.	Buy	858	Restricted Stock Units
2023-06-09	Garlikov Julie	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yenyou	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yongxiang	Buy	858	Restricted Stock Units
2023-06-09	Sit Swan	Buy	858	Restricted Stock Units

INSIDER POWER
-51.88
Last 96 transactions
Buy: 2 335 940 \| Sell: 2 184 002

ボリューム相関

長: -0.22 (neutral)

短: -0.41 (neutral)

Signal:(20.699) Neutral

NovaBay Pharmaceuticals 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

NovaBay Pharmaceuticals 相関 - 通貨/商品

0.00
( neutral )

NovaBay Pharmaceuticals 財務諸表

Annual	2023
収益:	$14.73M
総利益:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2023
収益:	$14.73M
総利益:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2022
収益:	$14.40M
総利益:	$7.78M (54.02 %)
EPS:	$-10.10

FY	2021
収益:	$8.42M
総利益:	$5.65M (67.03 %)
EPS:	$-9.42

Financial Reports:

No articles found.

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.